I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Syövän immuunihoidot - kuka hyötyy, kuka ei?:
Peltonen, Karita
;
Mikhailenko, Elizaveta
;
Peltola, Katriina
.
Peltonen , K , Mikhailenko , E , Peltola , K & Mustjoki , S 2022 , ' Syövän immuunihoidot - kuka hyötyy, kuka ei? ' , Duodecim , Vuosikerta. 138 , Nro 16 , Sivut 1387-1394 .. , 2023
Link:
http://hdl.handle.net/10138/563641
RT Journal T1
Syövän immuunihoidot - kuka hyötyy, kuka ei?
UL https://suche.suub.uni-bremen.de/peid=base-ftunivhelsihelda:oai:helda.helsinki.fi:10138_563641&Exemplar=1&LAN=DE A1 Peltonen, Karita A1 Mikhailenko, Elizaveta A1 Peltola, Katriina A1 Mustjoki, Satu PB Kustannus Oy Duodecim YR 2023 K1 Neoplasms K1 +classification K1 +etiology K1 +immunology K1 +therapy K1 Immunotherapy K1 Biomarkers K1 Tumor K1 B7-H1 Antigen K1 Microsatellite Instability K1 DNA Repair K1 T-Lymphocytes K1 3122 Syöpätaudit JF Peltonen , K , Mikhailenko , E , Peltola , K & Mustjoki , S 2022 , ' Syövän immuunihoidot - kuka hyötyy, kuka ei? ' , Duodecim , Vuosikerta. 138 , Nro 16 , Sivut 1387-1394 . LK http://hdl.handle.net/10138/563641 DO http://hdl.handle.net/10138/563641 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)